MENLO THERAPEUTICS INC's ticker is MNLO and the CUSIP is 586858102. A total of 1 filers reported holding MENLO THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $79,000 | -99.2% | 46,217 | -97.9% | 0.00% | -100.0% |
| Q4 2019 | $10,059,000 | +3.3% | 2,168,013 | -0.2% | 0.05% | -7.4% |
| Q3 2019 | $9,736,000 | -27.0% | 2,173,264 | -2.4% | 0.05% | -27.0% |
| Q2 2019 | $13,334,000 | -24.7% | 2,226,192 | -1.4% | 0.07% | -27.5% |
| Q1 2019 | $17,716,000 | +224.5% | 2,256,903 | +70.3% | 0.10% | +200.0% |
| Q4 2018 | $5,460,000 | -41.5% | 1,325,375 | +40.0% | 0.03% | -32.0% |
| Q3 2018 | $9,326,000 | +3660.5% | 946,804 | +2999.4% | 0.05% | +4900.0% |
| Q2 2018 | $248,000 | – | 30,548 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 1,461,552 | $11,473,000 | 9.29% |
| Vivo Capital, LLC | 4,011,236 | $31,488,000 | 3.14% |
| DAFNA Capital Management LLC | 600,030 | $4,710,000 | 2.03% |
| GREAT POINT PARTNERS LLC | 2,057,027 | $16,148,000 | 1.60% |
| MANGROVE PARTNERS IM, LLC | 561,138 | $4,405,000 | 0.59% |
| Alambic Investment Management, L.P. | 66,996 | $526,000 | 0.22% |
| FIRST MANHATTAN CO. LLC. | 2,256,903 | $17,716,000 | 0.10% |
| Orbimed Advisors | 633,920 | $4,976,000 | 0.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 198,451 | $1,558,000 | 0.06% |
| Baker Brothers Advisors | 700,000 | $5,495,000 | 0.04% |